| Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir S Mallal, D Nolan, C Witt, G Masel, AM Martin, C Moore, D Sayer, ... The Lancet 359 (9308), 727-732, 2002 | 1772 | 2002 |
| Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, ... Nature 432 (7018), 769-775, 2004 | 1011 | 2004 |
| Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal Science 296 (5572), 1439-1443, 2002 | 933 | 2002 |
| Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection SA Mallal, M John, CB Moore, IR James, EJ McKinnon Aids 14 (10), 1309-1316, 2000 | 631 | 2000 |
| Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and … TM Allen, M Altfeld, SC Geer, ET Kalife, C Moore, KM O'sullivan, ... Journal of virology 79 (21), 13239-13249, 2005 | 401 | 2005 |
| Predisposition to nevirapine hypersensitivity associated with HLA-DRB1* 0101 and abrogated by low CD4 T-cell counts AM Martin, D Nolan, I James, P Cameron, J Keller, C Moore, E Phillips, ... Aids 19 (1), 97-99, 2005 | 391 | 2005 |
| Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy M John, CB Moore, IR James, D Nolan, RP Upton, EJ McKinnon, ... Aids 15 (6), 717-723, 2001 | 340 | 2001 |
| Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes N Frahm, P Kiepiela, S Adams, CH Linde, HS Hewitt, K Sango, ... Nature immunology 7 (2), 173-178, 2006 | 293 | 2006 |
| Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA A Leslie, D Kavanagh, I Honeyborne, K Pfafferott, C Edwards, T Pillay, ... The Journal of experimental medicine 201 (6), 891-902, 2005 | 292 | 2005 |
| Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation C Pace, J Keller, D Nolan, I James, S Gaudieri, C Moore, S Mallal Journal of virology 80 (18), 9259-9269, 2006 | 153 | 2006 |
| Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression S Gaudieri, D DeSantis, E McKinnon, C Moore, D Nolan, CS Witt, ... Genes & Immunity 6 (8), 683-690, 2005 | 152 | 2005 |
| Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients M John, EJ McKinnon, IR James, DA Nolan, SE Herrmann, CB Moore, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 33 (1), 29-33, 2003 | 142 | 2003 |
| HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response ME Feeney, Y Tang, K Pfafferott, KA Roosevelt, R Draenert, A Trocha, ... The Journal of Immunology 174 (12), 7524-7530, 2005 | 131 | 2005 |
| Tumour necrosis factor-alpha gene-238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy D Nolan, C Moore, A Castley, D Sayer, C Mamotte, M John, I James, ... Aids 17 (1), 121-123, 2003 | 129 | 2003 |
| Ribitol dehydrogenase of Klebsiella aerogenes. Sequence and properties of wild-type and mutant strains JM Dothie, JR Giglio, CB Moore, SS Taylor, BS Hartley Biochemical Journal 230 (3), 569-578, 1985 | 44 | 1985 |
| Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1 M John, CB Moore, IR James, SA Mallal Antiviral therapy 10 (4), 551-555, 2005 | 42 | 2005 |
| THEORIES OF THUNDERSTORM ELECTRIFICATION. BJ Mason, M CB | 31 | 1976 |
| Protease inhibitors and nucleoside analogue reverse transcriptase inhibitors interact to cause subcutaneous fat wasting in patients with HIV infection S Mallal, M John, C Moore, I James, E Mckinnon 7th European Conference on Clinical Aspects and Treatment of HIV-Infection, 1999 | 27 | 1999 |
| Periodontal attachment loss in HIV‐infected patients is associated with the major histocompatibility complex 8.1 haplotype (HLA‐A1, B8, DR3) P Price, DM Calder, CS Witt, RJN Allcock, FT Christiansen, GR Davies, ... Tissue Antigens 54 (4), 391-399, 1999 | 23 | 1999 |
| Association-based predictions of pathogen characteristics DE Heckerman, S Mallal, CM Kadie, CB Moore, N Jojic US Patent 8,000,900, 2011 | 15 | 2011 |
